Stay updated on AZD8233 Safety in Elevated LDL-C Levels Clinical Trial

Sign up to get notified when there's something new on the AZD8233 Safety in Elevated LDL-C Levels Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AZD8233 Safety in Elevated LDL-C Levels Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the record for AstraZeneca’s Phase 1 AZD8233 trial, including study design, eligibility, outcome measures, and information about sharing participant data.
    Difference
    78%
    Check dated 2026-11-08T09:26:36.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.2 to v3.8.0; the displayed page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T11:13:25.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A notice appears above the page announcing NIH website transition updates and stating that NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T11:13:35.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error page, with the displayed site revision changing from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T11:47:23.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T13:57:53.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The study record page now renders a 403 Forbidden error screen with the site header/footer, replacing the expected content for the NCT03593785 record.
    Difference
    24%
    Check dated 2026-09-20T15:47:24.000Z thumbnail image

Stay in the know with updates to AZD8233 Safety in Elevated LDL-C Levels Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AZD8233 Safety in Elevated LDL-C Levels Clinical Trial page.